Therapeutic-dose anticoagulation may improve COVID-19 outcomes for noncritical inpatients

… improve outcomes for noncritically ill patients hospitalized with COVID-19, though fewer therapeutic dose-treated patients died at 30 days.

Read more at www.healio.com